MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    A CASE OF MEIGE SYNDROME IN INDONESIA TREATED WITH HALOPERIDOL

    K. Kandhisa, EA. Albertin, MG. Gaharu (Jakarta, Indonesia)

    Objective: To give a brief picture about the challenge of diagnosing and treating patients with Meige syndrome and to report a case of Meige syndrome…
  • 2022 International Congress

    Cognitive Function in Late-life and Parkinson’s Disease Neuropathology at Death

    R. Abbott, G. Ross, H. Petrovitch, K. Masaki, J. Uyehara-Lock, C. Tanner (Ansan-si, Republic of Korea)

    Objective: To examine the association between cognitive function in late-life and Parkinson’s disease (PD) neuropathology at death, including 1) neuron loss in the locus coeruleus…
  • 2022 International Congress

    Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study

    C. Liguori, C. de Masi, M. Spanetta, M. Fernandes, R. Cerroni, E. Garasto, M. Pierantozzi, N. Mercuri, A. Stefani (Rome, Italy)

    Objective: The present study aimed to explore the effect of safinamide treatment on NMS and quality of life in motor-fluctuating PD patients. Background: Parkinson’s disease…
  • 2022 International Congress

    Continuous Dopaminergic Stimulation (CDS), different infusion rates

    L. Quirós Illán, L. Ruiz-Escribano Menchen, JP. Cabello, F. Villanueva, I. Martin, A. Garcia Maruenda, P. Nieto Palomares, RE. Ibañez, J. Vaamonde Gamo (Ciudad Real, Spain)

    Objective: Physiopathological and therapeutic discussion of motor complications and dyskinesias in patients treated with continuous dopaminergic stimulation Background: Levodopa -induced motor complications remain an important…
  • 2022 International Congress

    Benefits and Risks of Staged Bilateral versus Unilateral VIM DBS for Essential Tremor

    P. Prakash, G. Deuschl, S. Ozinga, K. Mitchell, B. Cheeran, P. Larson, A. Merola, S. Groppa, T. Tomlinson, J. Ostrem (SAN FRANCISCO, USA)

    Objective: To compare the benefits and risks of staged bilateral versus unilateral VIM DBS using the largest ET DBS clinical trial dataset available to date.…
  • 2022 International Congress

    Psychometric properties and construct validity of the Parkinson’s Disease-Cognitive Rating Scale (PD-CRS) in Colombia.

    B. Muñoz-Ospina, H. Clavijo-Moran, D. álvarez-García, G. Pinilla-Monsalve, J. Orozco Velez (Cali, Colombia)

    Objective: Assess the psychometric properties of PD-CRS in a Colombian population. Background: Cognitive impairment is frequent amongst people living with Parkinson’s disease: up to 40%…
  • 2022 International Congress

    Intestinal microbial dysbiosis promotes prebiotic-reversible inflammation in Parkinson’s disease

    R. Manfready, D. Hall, C. Goetz, A. Keshavarzian (Chicago, USA)

    Objective: To determine the functional effects of disrupted intestinal microbiota in Parkinson’s disease (PD), particularly the impacts of dysbiosis on inflammation, neuroprotective hormone secretion, and…
  • 2022 International Congress

    Risk and Protective Substances among the Parkinson Disease Patients in Palembang Municipality

    MRO. Odiesta, SM. Marisdina, EB. Bahar (Palembang, Indonesia)

    Objective: The aim of the study was to describe risks and protective consumptions and habits among the Parkinson's Disease (PD) Patients in Palembang Municipality Background:…
  • 2022 International Congress

    Illness perception in patients with Functional Movement Disorders: a case series

    D. Campo-Caballero, L. Martínez, B. Martín, P. Rada, M. Kurtis, I. Pareés (San Sebastián, Spain)

    Objective: To assess illness perception (IP) in a cohort of patients with Functional Movement Disorders(FMD) Background: IP is the process by which individuals respond to…
  • 2022 International Congress

    Development of a patient journey map for people living with cervical dystonia

    M. Benson, A. Albanese, K. Bhatia, P. Cavillon, L. Cuffe, K. König, C. Reinhard, H. Graessner (Brussels, Belgium)

    Objective: As part of the ongoing European Reference Networks for Rare Neurological Diseases (ERN-RND) program, we aimed to develop a cervical dystonia patient journey map…
  • « Previous Page
  • 1
  • …
  • 91
  • 92
  • 93
  • 94
  • 95
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley